North America Proteomics Market

The North America proteomics market is projected to reach USD 25.62 billion by 2030 from USD 14.11 billion in 2025, at a CAGR of 12.7%. The growth of the North America proteomics market is attributed to several key factors, including strong funding and public-private programs and growing clinical proteomics momentum.

Several key players in the North America proteomics market with a strong footprint include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Revvity (US), Illumina Inc. (US), Promega Corporation (US), and Seer Inc. (US). These companies are scaling beyond traditional protein analysis tools into high-throughput, automated platforms that cover advanced sample preparation, mass spectrometry, next-generation sequencing-based proteomics, and advanced reagents and kits targeting complex biologics and multi-omics workflows. By adding new production capacity and launching integrated hardware-software ecosystems, they aim to extend their regional presence, covering the proteome and supporting personalized medicine programs across discovery, translational research, and clinical applications.

To know about the assumptions considered for the study download the pdf brochure

In September 2025, Illumina launched its Illumina Protein Prep assay, which can quantify about 9,500 human protein targets using NGS-based workflows to support large-scale multiomics.

Thermo Fisher Scientific (US) is a leading North American proteomics player, combining Orbitrap mass spectrometers, automated sample-prep workflows, and powerful software to deliver deep, quantitative insights into complex protein networks. By integrating Olink’s next-generation proteomics platform into its life-science portfolio, the company is positioning itself as a one-stop partner for biopharma and translational researchers who need scalable, multiplexed protein measurements to drive precision medicine programs.

Danaher Corporation (US) supports the regional proteomics market through companies such as SCIEX and Cytiva, which provide high-throughput LC-MS systems, capillary electrophoresis, and sample-handling technologies tailored for routine and advanced protein analysis. Recent collaborations, including SCIEX’s partnership with Evosep to co-sell standardized high-throughput proteomics workflows, are making robust, reproducible protein quantification more accessible to pharma and biotech labs across North America.

AAgilent Technologies (US) underpins North American proteomics with integrated LC-MS platforms, including triple-quadrupole and Q-TOF systems, coupled to standardized workflows and Spectrum Mill software for high-confidence peptide and protein quantitation. Through ongoing applications work and collaborations focused on plasma and targeted proteomics, Agilent helps research and clinical labs achieve sensitive, reproducible measurements that fit seamlessly into broader multi-omics and biomarker discovery pipelines.

Market Ranking

 Thermo Fisher Scientific brings together Orbitrap mass spectrometers, Olink-powered high-plex assays, and streamlined workflows, enabling researchers to move from raw samples to decision-ready proteomic data with fewer handoffs. Danaher, through platforms such as SCIEX and Cytiva, focuses on standardized, high-throughput LC-MS and sample-handling solutions that make complex proteomics runs more routine for pharma and core labs. Agilent Technologies complements this with integrated LC-MS systems and Spectrum Mill software, providing labs with robust peptide quantitation and data-analysis tools that integrate neatly into multi-omics pipelines. Bio-Rad Laboratories adds user-friendly protein separation, chromatography, and assay workflows that help biopharma teams quickly characterize biologics and biosimilars without over-engineering their setups. Revvity rounds out the landscape with protein analysis platforms and automated instruments that compress assay times and simplify method transfer, making it easier for discovery teams and CDMOs to scale promising proteomic assays into validated, routine use.

Related Reports:

North America Proteomics Market by Instrumentation (Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray), Reagent (Immunoassay), Service (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery)- Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com